Epigenetic Company EpigenCare Debuts $99 Version of its SKINTELLI Personalized Skincare DNA Test by EpigenCare News
FARMINGDALE, N.Y., December 23, 2020 —EpigenCare Inc., a biotechnology company specializing in consumer epigenetics, launched its new version of its SKINTELLI personalized skincare test. The product, which is a direct-to-consumer DNA test, looks at the current quality of an individual’s skin through epigenetic mechanisms such as DNA methylation. This new version, dubbed the “Standard” tier, is offered at a $99 price point, significantly lower than its first version that is priced at $399.
The original SKINTELLI test, now classified as the “Advanced” option, uses next-generation sequencing to determine the activity levels of one’s genes that are responsible for multiple skin quality aspects including skin aging, moisture retention, and pigmentation. The new test uses a methylation-specific PCR method that has particularly weight in its algorithm on skin aging, from which other additional quality factors can be derived from in a cost-effective manner. This more affordable method also significantly decreases expected turnaround time while still maintaining accurate results.
In late 2019, EpigenCare successfully validated its algorithm model of accurately measuring epigenetic aging through a participant study during its early beta phase. After gathering aggregate data in 2020 and refining its data model, the company now also offers a free questionnaire-based product that correlates users’ answers to its lab data via artificial intelligence. Subsequently, three tiered options are now offered: Basic, Standard, and Advanced, with the latter being the most comprehensive version of the test.
Published by EpigenCare News, December 23, 2020
Follow us on Linkedin!